Gallbladder Carcinoma Non-Resectable
1 clinical trials · Condition
◉ Watch Gallbladder Carcinoma Non-Resectable
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients (NCT03473574) | AIO-Studien-gGmbH | 2018-05-02 |
Track Gallbladder Carcinoma Non-Resectable automatically
Every clearance here is in the API, with alerts when new ones post.